Similar articles

• Individualizing therapy for metastatic colorectal cancer.

  Turja J, Grothey A. Turja J, et al. Oncology (Williston Park). 2008 Nov 30;22(13):1479-81. Oncology (Williston Park). 2008. PMID: 19227569 No abstract available.
• [Chemotherapy in colorectal carcinoma].

  Schmiegel W, Petrasch S. Schmiegel W, et al. Internist (Berl). 1994 Dec;35(12):1086-94. Internist (Berl). 1994. PMID: 7533749 Review. German. No abstract available.
• [Therapeutic strategies in colorectal cancer].

  Flieger D, Keller R, Fischbach W. Flieger D, et al. Dtsch Med Wochenschr. 2003 Sep 12;128(37):1902-7. doi: 10.1055/s-2003-42159. Dtsch Med Wochenschr. 2003. PMID: 12970825 Review. German. No abstract available.
• Multiagent regimens for metastatic colorectal cancer: if some is good, more must be better.

  Allegra C, George T Jr, Yothers G. Allegra C, et al. J Natl Cancer Inst. 2011 Jan 5;103(1):4-5. doi: 10.1093/jnci/djq483. Epub 2010 Dec 1. J Natl Cancer Inst. 2011. PMID: 21123834 No abstract available.
• [Progress in adjuvant and palliative chemotherapy of colorectal cancer: current status and perspectives].

  Scheithauer W. Scheithauer W. Wien Klin Wochenschr. 1993;105(20):568-79. Wien Klin Wochenschr. 1993. PMID: 7505075 Review. German.